Publication|Articles|February 18, 2026
- Pharmaceutical Executive: February 2026
- Volume 46
- Issue 1
Pharmaceutical Executive: February 2026 Interactive Digital Edition
View the Pharmaceutical Executive February 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
4 months ago
A New Pharma Playbook4 months ago
When Friction Meets Force in Clinical Research4 months ago
Today’s China Crucible: What It Means for Pharma4 months ago
Taking Advantage of ‘Hidden Gem’ Talent Hubs5 months ago
To Build or to Buy: Determining Your AI PathAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly to Deny 340B Drug Pricing Due to Claims-Data Policy: Report
2
What’s Trending in Oncology? A Discussion Following ASCO 2026 with Anne Marie Robertson from EVERSANA
3
New FDA Draft Guidance Targets Gene Therapy Submission Burden by Allowing Use of Existing CMC and Scientific Knowledge
4
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
5
